Abstract:Editorial Office Annals of Translational Medicine Submitted Jul 21, 2024. Accepted for publication Aug 02, 2024. Published online Sep 05, 2024. doi: 10.21037/atm-2024-9 Erratum to: Ann Transl Med 2021;9:533 The article (1) titled "ESM1 promotes triple-negative breast cancer cell proliferation through activating AKT/NF-κB/Cyclin D1 pathway" (doi: 10.21037/atm-20-7005), unfortunately contains several errors that need to be corrected. The image in the upper right corner of Figure 2F, which represents the migration of the control shRNA-expressing MDA-MB-231 cells, was selected incorrectly. This image should be replaced with the correct one. In the legend of Figure 2, the order of the parts corresponding to Figure 2E-2I was incorrect. The correct order is: (E) colony formation assay on MDA-MB-231; (F) migration assay on MDA-MB-231; (G) migration assay on MDA-MB-468; (H) invasion assay on MDA-MB-231; (I) invasion assay on MDA-MB-468. The caption "MDA-MB-468" in Figure 4 was accidentally misplaced between Figure 4D and Figure 4F, which should be at the bottom of Figure 4C . In the legend of Figure 4, the order of the parts corresponding to Figure 4C-4F was incorrect. The correct order is: (C) CCK-8 assay on MDA-MB-468; (D) migration assay on MDA-MB-231; (E) migration assay on MDA-MB-468; (F) invasion assay on MDA-MB-231. Figure 2F in the original article: The legend of Figure 2 in the original article: Caption "MDA-MB-468" in Figure 4 in the original article: The legend of Figure 4 in the original article: The updated version of Figure 2 , containing the correct image for the "Control" in Figure 2F , and the updated version of Figure 4 with the correct position of the caption "MDA-MB-468", together with the correct legends for both figures, are shown below. These errors did not significantly affect either the results or the conclusions of the paper. Click here to view the updated version of the article. Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.

Correction: Epigenetic Regulation of NAMPT by NAMPT-AS Drives Metastatic Progression in Triple-Negative Breast Cancer

Correction: PRMT5 Circular RNA Promotes Metastasis of Urothelial Carcinoma of the Bladder Through Sponging Mir-30C to Induce Epithelial–Mesenchymal Transition

Erratum to ESM1 promotes triple-negative breast cancer cell proliferation through activating AKT/NF-κB/Cyclin D1 pathway

Correction To: Early Presence of Anti-Angiogenesis-related Adverse Events As a Potential Biomarker of Antitumor Efficacy in Metastatic Gastric Cancer Patients Treated with Apatinib: a Cohort Study

Correction: KRAS/NF-κB/YY1/miR-489 Signaling Axis Controls Pancreatic Cancer Metastasis

Erratum: Artemin is estrogen regulated and mediates antiestrogen resistance in mammary carcinoma

Correction To: Methylseleninic Acid Suppresses Breast Cancer Growth Via the JAK2/STAT3 Pathway

Correction: Primary Tumor-Derived Exosomes Facilitate Metastasis by Regulating Adhesion of Circulating Tumor Cells Via SMAD3 in Liver Cancer

[Corrigendum] A Regulation Loop Between Nrf1α and MRTF‑A Controls Migration and Invasion in MDA‑MB‑231 Breast Cancer Cells.

Publisher Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer (Nature Nanotechnology, (2019), 14, 4, (388-397), 10.1038/s41565-019-0381-6)

Correction: Epigenetic loss of AOX1 expression via EZH2 leads to metabolic deregulations and promotes bladder cancer progression

Correction To: M6a Mrna Methylation Regulates CTNNB1 to Promote the Proliferation of Hepatoblastoma

[Corrigendum] P2Y2 receptor promotes the migration and invasion of breast cancer cells via EMT‑related genes Snail and E‑cadherin

Correction To: C-Src Confers Resistance to Mitotic Stress Through Inhibition of DMAP1/Bub3 Complex Formation in Pancreatic Cancer

[Corrigendum] Upregulation of centromere protein M promotes tumorigenesis: A potential predictive target for cancer in humans

[Corrigendum] Inhibition of sphingosine-1-phosphate phosphatase 1 promotes cancer cells migration in gastric cancer: Clinical implications.

Publisher Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer

Corrigendum to “Blockade of miR-3614 maturation by IGF2BP3 increases TRIM25 expression and promotes breast cancer cell proliferation” [EBioMedicine 41 (2019) 357–369]

Corrigendum for “lncrna EPB41L4A-AS1 Regulates Glycolysis and Glutaminolysis by Mediating Nucleolar Translocation of HDAC2” [ebiomedicine 41 (2019) 200–213]

Corrigendum to “the CD24+ Cell Subset Promotes Invasion and Metastasis in Human Osteosarcoma” [ebiomedicine 51(2020)102598]

Correction: Author Correction: Menin enhances c-Myc-mediated transcription to promote cancer progression